about
Stage migration vs immunology: The lymph node count story in colon cancerSMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.Development of the competency-based medical curriculum for the new Augsburg University Medical SchoolExpression of Abelson interactor 1 (Abi1) correlates with inflammation, KRAS mutation and adenomatous change during colonic carcinogenesis.Drug induced interstitial lung disease.Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.Galectin-3 and Cyclin D3 Immunohistochemistry and Tumor Dimensions Are Useful in Distinguishing Follicular Oncocytic Carcinomas from Oncocytic Adenomas of the Thyroid.Circulating cytokeratin-positive cells and tumor budding in colorectal cancer.Prognostic significance of tumor budding in gastrointestinal tumors.Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K521 Polymorphism.Tumor Budding, uPA, and PAI-1 in Colorectal Cancer: Update of a Prospective Study.In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components.Lymph node hypoplasia is associated with adverse outcomes in node-negative colon cancer using advanced lymph node dissection methods.Number of Intratumoral T Lymphocytes Is Associated With Lymph Node Size, Lymph Node Harvest, and Outcome in Node-Negative Colon Cancer.The role of lymph node size and FOXP3+ regulatory T cells in node-negative colon cancer.Clinical Significance of International Union Against Cancer pN Staging and Lymph Node Ratio in Node-Positive Colorectal Cancer after Advanced Lymph Node Dissection.Lymph node size as a simple prognostic factor in node negative colon cancer and an alternative thesis to stage migration.Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection.Methylene blue-assisted lymph node dissection technique is not associated with an increased detection of lymph node metastases in colorectal cancer.The clinical significance of lymph node size in colon cancer.Endoscopic submucosal dissection in large sessile lesions of the rectosigmoid: learning curve in a European center.[Lymph node staging in gastrointestinal cancer. Combination of methylene blue-assisted lymph node dissection and ex vivo sentinel lymph node mapping].Combination of ex vivo sentinel lymph node mapping and methylene blue-assisted lymph node dissection in gastric cancer: a prospective and randomized study.A new concept for the role of ex vivo sentinel lymph nodes in node-negative colorectal cancer.Injecting methylene blue into the inferior mesenteric artery assures an adequate lymph node harvest and eliminates pathologist variability in nodal staging for rectal cancer.Methylene blue-assisted lymph node dissection in combination with ex vivo sentinel lymph node mapping in gastric cancer.Methylene blue-assisted lymph node dissection in colon specimens: a prospective, randomized study.[Lymph node preparation in colorectal cancer. Ex vivo methylene blue injection as a novel technique to improve lymph node visualization].Methylene blue injection into the rectal artery as a simple method to improve lymph node harvest in rectal cancer.[Laparoscopic rectal resection technique].Intraparotid classical and nodular lymphocyte-predominant Hodgkin lymphoma: pattern analysis with emphasis on associated lymphadenoma-like proliferations.Lipomatous salivary gland tumors: a series of 31 cases spanning their morphologic spectrum with emphasis on sialolipoma and oncocytic lipoadenoma.Recurrent Somatic PDGFRB Mutations in Sporadic Infantile/Solitary Adult Myofibromas But Not in Angioleiomyomas and Myopericytomas.SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.Metastatic Malignant Melanoma With Complete Loss of Differentiation Markers (Undifferentiated/Dedifferentiated Melanoma): Analysis of 14 Patients Emphasizing Phenotypic Plasticity and the Value of Molecular Testing as Surrogate Diagnostic Marker.Endoscopic submucosal dissection for early rectal neoplasia: experience from a European center.[Percutaneous Phil™-Embolization for Preoperative Therapy of Carotid Body Paragangliomas].Multiple sporadic gastrointestinal stromal tumours arising at different gastrointestinal sites: pattern of involvement of the muscularis propria as a clue to independent primary GISTs.Sclerosing nodular lesions of the gastrointestinal tract containing large numbers of IgG4 plasma cellsFrequency and clinicopathological features of fibroelastotic changes in the gastrointestinal tract
P50
Q26775953-DFF92CF8-5007-4727-AAF3-1D0418581B4CQ30252961-70DCCBAA-53C2-4409-B264-AC598BA65511Q33743807-0D6FD001-B5CF-4DE7-B0CD-85CFEA673ED6Q34342261-717DD62A-1D50-481B-ABDF-519634E89F07Q34641494-BD7DBA0A-D137-4759-876F-7CD0C65187B3Q36148358-5056274F-A95B-49DC-86B2-5E80F661EF94Q36271908-BBEDCDEB-9601-4F80-AB8C-E567332C48D3Q37482924-21CACDD4-82B7-4317-8D64-8A9AD94EB672Q37945638-43F715E6-ED16-495A-AC85-D642DAE521BAQ38723941-E642B67A-6600-42D2-AFDC-D9BC0BCA0170Q38912093-706F4086-028F-42FD-B11A-A75CEE7BE201Q39430735-2CF68074-CB8E-4F41-9D44-BAD2F2C0A892Q39995547-CEAA8D24-DE95-4C57-BEC2-48734C081990Q40383860-BCA50FA9-915F-476F-BD62-8AD82079EE76Q40460653-508429B8-FA55-44D4-A3B9-F7BF79E21984Q40815213-305FEBA8-45B0-40BE-A17B-BC23CABD7E7CQ41452294-75A3E67B-7938-43DD-8A4D-FCD24FB2FDDBQ41723130-B385869F-F8E0-4D38-A557-4C17350D0F88Q44814903-9D00DB90-8832-4D8E-9110-F5327FB5E379Q44955639-CD7F5C27-2C1F-4ACF-8742-43F74822D740Q46089226-7714232F-1975-4151-B907-12BFC0285FB5Q50239971-FBE26F34-FD63-40D4-A570-C0CFC1DD3376Q50278539-53AE6B96-38B1-4BF7-805B-0F6186F9F619Q50446634-55D8875E-3B7E-45F4-9699-EBF8F806A397Q50452281-00B44B8B-2155-4608-9B4F-A45DDEAAF020Q50453659-B101DFF2-AA4B-4700-8ED6-574BD228FDFFQ50455933-AE84A327-97F3-4B6D-890F-C8290934A94BQ50464105-E7B13A11-0E68-44BA-9D0F-6FFCF1B5947FQ50469230-D7928413-51D3-4B25-8C5C-0B10398FF8A0Q50506177-1A9F6CFE-A10A-4669-8133-E79B85658FBCQ51028664-B48DEF6D-710F-46CE-91D9-24AD25325131Q51289199-E5D47C72-5CD9-4C24-A07C-F93C4C0D72D6Q51366410-6FB21266-0514-4458-82BE-5A6156605BF1Q52146996-85A31690-3685-4C58-8078-235118A7DEF6Q52861766-750733CE-A897-4D0B-B0B2-4380C23C2FD2Q52963137-5969AA86-E6E8-4B38-A5D0-5EB2FE54C81CQ53076657-10809D9D-E88B-4121-800E-28932DD6A635Q54735090-25BB1F71-BDAA-42CD-AEC3-9E786F39BD15Q57422121-E30C88BA-8EF8-4B13-B5E1-40228D543908Q57524877-1F8812E0-99BE-4BA5-95F2-E466D4C627E1
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Bruno Märkl
@ast
Bruno Märkl
@en
Bruno Märkl
@es
Bruno Märkl
@nl
Bruno Märkl
@sl
type
label
Bruno Märkl
@ast
Bruno Märkl
@en
Bruno Märkl
@es
Bruno Märkl
@nl
Bruno Märkl
@sl
prefLabel
Bruno Märkl
@ast
Bruno Märkl
@en
Bruno Märkl
@es
Bruno Märkl
@nl
Bruno Märkl
@sl
P106
P1153
16550250200
P21
P214
1786155769085427880006
P31
P496
0000-0002-7704-850X
P735
P7859
viaf-1786155769085427880006